NG-Test® CTX-M Multi
ESBL detection in just 15 minutes with NG-Test® CTX-M Multi. Now FDA-cleared!
Long Description
The NG-TEST® CTX-M Multi is now FDA-cleared! This innovative, FDA-cleared solution is revolutionizing the rapid detection of ESBL-producing bacteria. Designed for the qualitative detection of CTX-M enzymes (groups 1, 2, 8, 9, and 25), this advanced in vitro diagnostic test delivers results from isolated colonies in just 15 minutes. Its ease of use and minimal training requirements make it ideal for various clinical settings, including hospitals and long-term care facilities, significantly improving turnaround times for critical diagnostic information. By providing a quick and accurate assessment of CTX-M mediated ESBLs, the NG-TEST® CTX-M Multi is crucial in the fight against antimicrobial resistance, enabling faster, more informed treatment decisions. This robust, room-temperature stable test eliminates the need for specialized equipment, streamlining laboratory workflows and enhancing patient care. CTX-M Multi is exclusively distributed in the US and Canada through Hardy Diagnostics.
High Resolution Image
Small Image
Large Image
Category Product Showcase